Diamox (acetazolamide) is a medication that blocks an enzyme called carbonic anhydrase, which changes how your kidneys handle sodium, bicarbonate, and water. By disrupting this enzyme, Diamox forces your body to excrete more sodium and water through urine instead of reabsorbing them. This single mechanism makes it useful across a surprisingly wide range of conditions, from altitude sickness and glaucoma to fluid buildup in heart failure.
How Diamox Works in the Body
Carbonic anhydrase is an enzyme concentrated in your kidneys and red blood cells. In the kidneys, it normally helps reabsorb sodium, bicarbonate, and chloride back into your bloodstream. When Diamox blocks this enzyme, those substances get flushed out in your urine instead, and excess water follows them. The net effect is that your urine becomes more alkaline (because of all the bicarbonate leaving your body), and your blood becomes slightly more acidic.
That mild acid shift in your blood is actually the key to several of Diamox’s therapeutic uses. It’s what triggers your body to breathe faster at high altitude, what reduces fluid production in your eyes, and what lowers pressure around your brain. One drug, one mechanism, multiple applications.
Preventing Altitude Sickness
Diamox is the most widely used medication for preventing acute mountain sickness. When you ascend quickly to high elevations, your body struggles to get enough oxygen. Diamox speeds up your acclimatization by making your blood slightly acidic, which signals your lungs to breathe deeper and faster, improving oxygen intake.
The CDC recommends 125 mg every 12 hours for most adults, starting the day before you begin climbing and continuing for the first two days at altitude (or longer if you keep ascending). People over 100 kg may need 250 mg twice daily. This lower 125 mg dose is preferred because it minimizes side effects while still being effective. Diamox doesn’t mask symptoms of altitude sickness the way a painkiller would. It genuinely helps your body adjust to thinner air.
Lowering Eye Pressure in Glaucoma
Inside your eye, a fluid called aqueous humor is constantly produced and drained. In glaucoma, pressure builds up when this fluid doesn’t drain properly. Diamox reduces the production of aqueous humor by blocking carbonic anhydrase in the eye, which lowers the pressure inside the eye.
The effect is substantial and fast. Studies in patients with open-angle glaucoma have shown pressure reductions between 15% and 34% within hours of taking the drug. One study found that even a modest 125 mg dose reduced eye pressure by 29% within two hours. At higher doses, reductions as large as 43.6% have been documented within three to five hours. Diamox is typically used as a short-term or adjunctive treatment alongside eye drops rather than as a standalone long-term therapy.
The medication comes in two forms: immediate-release tablets that work for 8 to 12 hours, and an extended-release version (Diamox Sequels) that maintains its effect for 18 to 24 hours per dose. For glaucoma patients who need sustained pressure control, the extended-release form can mean fewer doses per day.
Reducing Pressure Around the Brain
Idiopathic intracranial hypertension (IIH) is a condition where pressure inside the skull rises for no clear structural reason, causing severe headaches and vision problems. Because carbonic anhydrase plays a role in producing cerebrospinal fluid, Diamox can reduce that production and bring the pressure down.
A typical starting dose for IIH is 250 to 500 mg twice daily, with many patients gradually increasing over time. In a major clinical trial, 44% of participants reached a daily dose of 4 grams, though most tolerated around 1 gram per day. The evidence for Diamox in IIH is considered modest. Two randomized trials showed some benefits, but medical consensus acknowledges the data is limited, and not all physicians prescribe it for this condition. For patients with IIH, it remains one of the few available medical options alongside weight loss.
Boosting Fluid Removal in Heart Failure
When someone with heart failure is hospitalized with severe fluid overload, the standard treatment is loop diuretics (the class of drugs that includes furosemide). But some patients develop resistance to these drugs over time, and the diuretics stop working as effectively. Diamox targets a different part of the kidney than loop diuretics do, so adding it can restart the fluid removal process.
A recent meta-analysis found that adding Diamox to loop diuretics significantly increased both sodium and water output compared to loop diuretics alone. Patients excreted substantially more fluid during their hospital stays. That said, the analysis found no significant difference in overall mortality between the two groups, meaning Diamox helps move fluid but hasn’t been shown to improve survival on its own.
Common Side Effects
The most recognizable side effect of Diamox is tingling or numbness in your fingers, toes, and around your lips. This sensation, called paresthesia, is directly related to the drug’s effect on carbonic anhydrase and is common enough that it’s often considered a sign the medication is working. Using the lower 125 mg dose for altitude sickness helps minimize this.
One of the stranger effects: Diamox makes carbonated drinks taste flat or metallic. Carbonic anhydrase is present on taste receptors in your mouth, and when Diamox blocks it there, your tongue can no longer detect the “fizzy” sensation of carbonation. The bubbles are still present, but the taste is gone. Some people find this so unpleasant that they stop drinking sodas entirely while on the drug.
Other reported side effects include diarrhea, nausea, fatigue, altered taste, tinnitus, and depression. At higher doses used for conditions like IIH, side effects become more common, and periodic blood work to monitor electrolyte levels is generally recommended. Rarely, Diamox can contribute to kidney stones because of the changes it causes in urine chemistry.
Sulfa Allergy and Diamox
Diamox contains a sulfonamide group in its chemical structure, which has historically raised concerns for people with sulfa allergies. However, current pharmacological evidence suggests that cross-reactivity between sulfa antibiotics and Diamox is unlikely. The two types of drugs have different chemical structures in the specific regions that trigger allergic reactions. Sulfa antibiotics contain molecular features (an N1 ring and N4 amine group) that produce the reactive compounds responsible for allergic responses. Diamox lacks both of these features.
Multiple case reports and pharmacology reviews support the conclusion that patients who had allergic skin reactions to sulfa antibiotics can take Diamox without a cross-reaction. For people who experienced severe, life-threatening reactions to sulfa antibiotics, the decision requires more careful consideration, but the blanket warning against using Diamox in anyone with a sulfa allergy is not well supported by the evidence.